Biologics in COPD: The Road is Still Long and Winding
Saved in:
| Main Authors: | Konstantinos Kostikas, Athena Gogali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-05-01
|
| Series: | COPD |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2025.2467657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the Impact of Triple Therapy on Mortality in Copd: The End is the Beginning?
by: Konstantinos Kostikas, et al.
Published: (2022-12-01) -
Proposal for a 4-Level Classification System of Severe COPD Exacerbation According to Healthcare Resource Utilization
by: Georgios Hillas, et al.
Published: (2024-12-01) -
2025 GOLD Report: What is New and What is Noteworthy for the Practicing Clinician
by: Konstantinos Kostikas, et al.
Published: (2025-01-01) -
Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis
by: Christos Kyriakopoulos, et al.
Published: (2025-03-01) -
Real World Study on the Reasons for eScalation or de-Escalation of Inhaled ThEraPies in COPD Patients: the STEPINCOPD Multicenter Observational Study
by: Argyris Tzouvelekis, et al.
Published: (2024-12-01)